Cleveland Clinic is working with Masimo on a new partnership focused on hospital-based remote patient monitoring and virtual critical care.
WHY IT MATTERS
The work will include the integration of Cleveland Clinic’s critical care and non-critical care central patient monitoring platforms with Masimo’s Hospital Automation platform, according to the company, in an effort to provide tools for clinicians that offer “enhanced situational awareness and clinical decision-support for hospitalized patients, including the critically ill.”
The health system will also work with the vendor on initiatives around predictive analytics and other AI-based algorithms, with a special focus on cardiology, they say.
Cleveland Clinic already has a critical care and non-critical care central monitoring platform that enables continuous monitoring of vital signs for both intensive care and non-ICU patients, with RPM programs serving 11 hospitals. providing intensivist monitoring, 24/7 critical care nursing, and patient management.
Masimo’s Hospital Automation platform, meanwhile, is built around tools designed to help clinicians boost care not just at the bedside, but wherever the patient may be in the care continuum. Those technologies include monitoring and wearable sensors, high-fidelity medical device integration, applications for surveillance and data visualization and other AI-enabled technologies to help clinicians triage patients and spot changes in their conditions faster and more efficiently.
They’re powered by the company’s Halo engine, “which identifies deterioration patterns in multiple physiological parameters simultaneously,” Masimo says.
Cleveland Clinic will work with the developer to jointly develop other Halo-based decision-support tools to support clinicians with earlier detection of adverse events in patients of varying acuities. With Masimo, the health system also aims to bring its innovations and patient benefits “to other healthcare systems in the future,” the company said in a news release.
ON THE RECORD
“We look forward to exploring the effects of next-gen inpatient wearables, and as the capabilities of AI continue to advance, studying the potential impact on the care of cardiac patients, including those undergoing cardiac surgery,” said Dr. Thomas Callahan, staff cardiologist at Cleveland Clinic’s Heart, Vascular & Thoracic Institute and principal investigator for the AI study, in a statement.
“By harnessing Masimo’s AI-powered decision support tools, automation solutions, and monitoring devices, alongside Cleveland Clinic’s vast clinical expertise and dedication to providing the highest quality, most innovative care, our partnership has the potential to significantly ease staff shortages, better standardize care, and promote intensivist- and specialist-led care,” added Masimo Founder and CEO Joe Kiani.
Mike Miliard is executive editor of Healthcare IT News
Email the writer: mike.miliard@himssmedia.com
Healthcare IT News is a HIMSS publication.
The HIMSS AI in Healthcare Forum is scheduled to take place Sept. 5-6 in Boston. Learn more and register.
